(5alpha,8xi,9xi,10xi,13xi,14xi)-Androstane-3,17-dione(CAS: 846-46-8)

Regulatory guidelines for (5alpha,8xi,9xi,10xi,13xi,14xi)-Androstane-3,17-dione (CAS: 846-46-8) include GHS classification, REACH regulations, as well as FDA and EPA requirements. GHS classifies the compound as a toxic substance. REACH regulations require registration and authorization for higher quantities, while FDA and EPA regulations ensure safe handling and disposal to protect human health and the environment.

In synthesis, alternatives to (5alpha,8xi,9xi,10xi,13xi,14xi)-Androstane-3,17-dione (CAS: 846-46-8) include other androstane derivatives and their analogs. Common alternatives include testosterone, dihydrotestosterone, and other androstanes. Isomers like 5alpha-androst-1,3,5(10)-triene-17-one are also available. These alternatives can serve similar purposes but may require different synthesis routes and handling procedures.

The market for (5alpha,8xi,9xi,10xi,13xi,14xi)-Androstane-3,17-dione (CAS: 846-46-8) is driven by research in hormone therapy and pharmacology. Recent trends indicate a growing interest in its use as a precursor for synthetic hormones. Research is also focusing on its potential in sports supplements and its role in aging research. Market demand is expected to increase due to these emerging applications and the expanding research field.

Waste containing (5alpha,8xi,9xi,10xi,13xi,14xi)-Androstane-3,17-dione (CAS: 846-46-8) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method, but ensure it meets environmental standards. Environmental protection precautions include minimizing waste generation and adhering to local regulations. Proper labeling and documentation are essential for safe and compliant disposal.